Patent details

Basic Information

Publication number:

EP3668522

PCT Application Number:

US2018046974

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP188467005

PCT Publication Number:

WO2019036670

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

EFFICACIOUS MRNA VACCINES

French Title of Invention:

VACCINS À BASE D'ARNM EFFICACES

German Title of Invention:

WIRKSAME MRNA-IMPFSTOFFE

SPC Number:

Dates

Filing date:

17/08/2018

Grant date:

11/09/2024

EP Publication Date:

24/06/2020

PCT Publication Date:

21/02/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

11/09/2024

EP B1 Publication Date:

11/09/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

17/08/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/09/2024

 

 

Name:

ModernaTX, Inc.

Address:

325 Binney Street, Cambridge, MA 02142, United States (US)

Inventor

1

Name:

CIARAMELLA, Giuseppe

Address:

United States (US)

2

Name:

HOGE, Stephen

Address:

United States (US)

Priority

1

Priority Number:

201762547665 P

Priority Date:

18/08/2017

Priority Country:

United States (US)

2

Priority Number:

201762560548 P

Priority Date:

19/09/2017

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/7088; A61K 39/145; A61K 9/51; G01N 33/50; A61P 31/16; A61K 47/69;

Publication

European Patent Bulletin

Issue number:

202437

Publication date:

11/09/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

01/09/2025

Annual Fee Number:

8

Annual Fee Amount:

99 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages